In high-fat diet–induced NAFLD mouse models and human NAFLD liver samples, CAV1 deficiency correlated with enhanced oxidative stress, inflammation, and fibrosis, whereas supplementation with a CAV1 scaffolding domain peptide restored ferroptosis resistance and improved hepatic outcomes [409]. Here, CAV1 is linked to metabolic dysfunction-associated steatotic liver disease.